Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger
Jonel Trebicka

Showing results (71-80 of 971) with videos related to

Pageof 98
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 24, 2018
When Should We Stop Treatment With Terlipressin and Albumin for Patients With Hepatorenal Syndrome?Thomas Reiberger
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Journal of Hepatology|February 2, 2016
Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patientsJonel Trebicka, Matthias von Heydebrand, Jennifer Lehmann, et al.
Frontiers in Immunology|September 4, 2023
Editorial: Acute-on-chronic liver failure: systemic inflammation and immunosuppressionOlaf Tyc, Yu Shi, Yu-Chen Fan, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 7, 2020
Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune DiseasesJinyang Zeng-Brouwers, Sony Pandey, Jonel Trebicka, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 13, 2019
Precipitants of Acute-on-Chronic Liver Failure: An Opportunity for Preventative Measures to Improve OutcomesGiuseppe Cullaro, Rajani Sharma, Jonel Trebicka, et al.
Clinical and Molecular Hepatology|November 11, 2025
Reply to Correspondence to "Predictive machine learning model in intensive care unit patients with acute-on-chronic liver failure and two or more organ failures"Mengyi Zhang, Yee Hui Yeo, Jian Zu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 11, 2017
Rationale for the use of statins in liver diseaseRobert Schierwagen, Frank Erhard Uschner, Fernando Magdaleno, et al.
Microvascular Research|May 16, 2009
Hepatic VASP upregulation in rats with secondary biliary cirrhosis by expression in the peribiliary vascular plexusMartin Hennenberg, Jonel Trebicka, Hans-Peter Fischer, et al.
Journal of Hepatology|August 4, 2018
Statins: Old drugs as new therapy for liver diseases?Elisa Pose, Jonel Trebicka, Rajeshwar P Mookerjee, et al.
Pageof 98

Showing results (71-80 of 971) with videos related to

Sort By:
Pageof 98
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 24, 2018
When Should We Stop Treatment With Terlipressin and Albumin for Patients With Hepatorenal Syndrome?Thomas Reiberger
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Journal of Hepatology|February 2, 2016
Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patientsJonel Trebicka, Matthias von Heydebrand, Jennifer Lehmann, et al.
Frontiers in Immunology|September 4, 2023
Editorial: Acute-on-chronic liver failure: systemic inflammation and immunosuppressionOlaf Tyc, Yu Shi, Yu-Chen Fan, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 7, 2020
Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune DiseasesJinyang Zeng-Brouwers, Sony Pandey, Jonel Trebicka, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 13, 2019
Precipitants of Acute-on-Chronic Liver Failure: An Opportunity for Preventative Measures to Improve OutcomesGiuseppe Cullaro, Rajani Sharma, Jonel Trebicka, et al.
Clinical and Molecular Hepatology|November 11, 2025
Reply to Correspondence to "Predictive machine learning model in intensive care unit patients with acute-on-chronic liver failure and two or more organ failures"Mengyi Zhang, Yee Hui Yeo, Jian Zu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 11, 2017
Rationale for the use of statins in liver diseaseRobert Schierwagen, Frank Erhard Uschner, Fernando Magdaleno, et al.
Microvascular Research|May 16, 2009
Hepatic VASP upregulation in rats with secondary biliary cirrhosis by expression in the peribiliary vascular plexusMartin Hennenberg, Jonel Trebicka, Hans-Peter Fischer, et al.
Journal of Hepatology|August 4, 2018
Statins: Old drugs as new therapy for liver diseases?Elisa Pose, Jonel Trebicka, Rajeshwar P Mookerjee, et al.
Pageof 98